Ilika Drives Forward in Solid-State Battery Revolution

Ilika Plc

Automakers and industrial players are actively investing in solid-state development, recognising its potential to redefine electric mobility and power systems. New cells under development are demonstrating impressive charge speeds and energy performance, with some capable of reaching high charge levels in under 20 minutes. Several companies aim to bring solid-state products into demonstration or early production stages within the next few years.

Within this dynamic sector, one company developing a clear niche is Ilika plc. The firm’s focus on solid-state technology spans both micro-scale and large-format cells. Its Stereax microbatteries target high-value applications like medical implants and industrial sensors, where reliability, longevity, and miniaturisation are key. At the same time, Ilika’s Goliath programme is building momentum in the automotive and high-power segment, with prototype cells already achieving industry benchmarks. Ilika’s use of an oxide-ceramic electrolyte, compatible with existing manufacturing lines, reduces the need for completely new infrastructure, a major advantage when scaling to volume production.

As interest in advanced battery technologies intensifies, firms that combine proven science with manufacturability are gaining traction. Ilika’s strategy to balance technical innovation with practical deployment makes it a strong participant in the ongoing shift to solid-state power.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Search